• ASH 2022
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Presentation 5
  • Keyslides Newsletter 1
    • Manier Keyslides
    • Dreyling Keyslides
    • Martin Keyslides
    • Abramson Keyslides
    • Litzow Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Presentation 5
  • Keyslides Newsletter 2
    • Lunning Keyslides
    • Broome Keyslides
    • Peffault De Latour Keyslides
    • Byrd Keyslides
    • Roeth Keyslides
  • Highlights Newsletter 3
    • Podcast with Prof. Peter Vandenberghe about some important updates on the use of axi-cel in patients with relapsed/refractory diffuse large B-cell lymphoma
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 3
    • Brown Keyslides
    • Kirkwood Keyslides
    • Capra Keyslides
    • Schetelig Keyslides
  • Highlights Newsletter 4
    • Podcast with Prof. John N. Allan (Weill Cornell Medicine, New York) about the updated results of the CAPTIVATE trial
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 4
    • Lunning Keyslides
    • Schetelig Keyslides
    • Manier Keyslides
    • Litzow Keyslides
• IWWM 2022
  • Highlights Newsletter 1
    • Podcast with Prof. Jorge Castillo about long-term follow-up of ibrutinib monotherapy in treatment-naïve Waldenström macroglobulinemia
    • Podcast with Prof. Evangelos Terpos about responses to COVID vaccination in patients with plasma cell neoplasms
    • Podcast with Prof. Constantine Tam about response to BTK inhibitor treatment in patients with Waldenström macroglobulinemia
    • Podcast with Prof. Christian Buske about the long-term follow-up of the iNNOVATE study
  • Highlights Newsletter 2
    • Podcast with Prof. Véronique Leblond about a phase II study exploring the “chemo-free” treatment association of idelalisib and obinutuzumab in relapsed or refractory WM
    • Podcast with Dr. Marzia Varettoni about the first results of the BIOWM study analysing the genomic landscape of WM patients and novel screening techniques
    • Podcast with Dr. Tina Bagratuni about a single-cell analysis of mutated and wildtype MYD88 WM
    • Podcast with Dr. Shirley D’Sa about Real-World safety and efficacy of ibrutinib in patients with WM: The UK experience
• EHA 2022
  • Highlights Newsletter 1
    • Podcast with Prof. Dr. Cappellini about the longer-term analysis of efficacy of luspatercept versus placebo in patients with transfusion-dependent beta-thalassemia enrolled in the BELIEVE study
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 1
    • Dytfeld Keyslides
    • Dickinson Keyslides
    • Garelius Keyslides
    • Rives Keyslides
  • Highlights Newsletter 2
    • Podcast with Prof. Dr. Radford about improved overall survival with first-line brentuximab vedotin plus chemotherapy in patients with stage III/IV classical Hodgkin lymphoma
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 2
    • Röth Keyslides
    • Sureda Keyslides
    • Hillmen Keyslides
    • Wang Keyslides
  • Highlights Newsletter 3
    • Podcast with Prof. Dr. Nicholas Short about the efficacy of Ponatinib and Blinatumomab for the treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 3
    • Bachy Keyslides
    • Russell Keyslides
    • Ghosh Keyslides
    • Eichhorst Keyslides
  • Highlights Newsletter 4
    • Podcast with Prof. Dr. Radford about improved overall survival with first-line brentuximab vedotin plus chemotherapy in patients with stage III/IV classical Hodgkin lymphoma
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 4
    • Rives Keyslides
    • Bachy Keyslides
    • Garelius Keyslides
    • Dytfeld Keyslides
• ASH 2021
  • Highlights Newsletter 1
    • Podcast with Carsten Niemann about time-limited Venetoclax and Ibrutinib for Patients with R/R CLL and Undetectable MRD
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 1
    • Goldschmidt Keyslides
    • Budde Keyslides
    • Locke Keyslides
    • Young Keyslides
  • Highlights Newsletter 2
    • Podcast with Prof. Satva Neelapu about Axi-cel for patients with R/R indolent non-Hodgkin lymphoma: the ZUMA-5 study
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 2
    • Thompson Keyslides
    • Rotterdam Keyslides
    • Tilly Keyslides
    • Mahon Keyslides
  • Highlights Newsletter 3
    • Podcast with dr Bert Heyrman about reimbursal of luspatercept in the treatment of low risk MDS: the MEDALIST trial
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 3
    • Döhner Keyslides
    • Mauro Keyslides
    • Comenzo Keyslides
    • Bishop Keyslides
  • Highlights Newsletter 4
    • Podcast with dr Talha Munir about ibrutinib plus venetoclax vs chlorambucil plus obinutuzumab for first-line treatment of chronic lymphocytic leukemia: the GLOW study
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 4
    • Locke Keyslides
    • Döhner Keyslides
    • Budde Keyslides
    • Tilly Keyslides
• EHA 2021
  • Highlights Newsletter 1
    • PODCAST with Dr. Martin Hutchings about brentuximab vedotin with chemotherapy in previously untreated Hodgkin lymphoma
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 1
    • Hillmen Keyslides
    • Taher Keyslides
    • Peffault de Latour Keyslides
    • Kuter Keyslides
  • Highlights Newsletter 2
    • PODCAST with Dr. David Miklos about ibrutinib in combination with corticosteroids in graft-versus-host disease
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 2
    • Facon Keyslides
    • Le Gouill Keyslides
    • Röth Keyslides
    • Miesbach Keyslides
  • Highlights Newsletter 3
    • PODCAST with Prof. Arnon Kater about fixed-duration ibrutinib and venetoclax for first-line treatment of CLL
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 3
    • Sharman Keyslides
    • Usmani Keyslides
    • Kastritis Keyslides
    • Ram Keyslides
  • Highlights Newsletter 4
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 4
    • Ram Keyslides
    • Le Gouill Keyslides
    • Hillmen Keyslides
    • Peffault de Latour Keyslides
• ASH 2020
  • Highlights Newsletter 1
    • PODCAST with prof. dr. Pieter Sonneveld about VRD consolidation treatment followed by maintenance therapy in transplant-eligible patients with multiple myeloma
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 1
    • Cutler Keyslides
    • Frangoul Keyslides
    • Zeiser Keyslides
    • Dimopoulos Keyslides
  • Highlights Newsletter 2
    • PODCAST with dr. Srdan Verstovsek about long term exposure to momelotinib in JAK inhibitor naïve and previously JAK inhibitor treated intermediate or high risk myelofibrosis patients
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 2
    • Brümmendorf keyslides
    • Döhner Keyslides
    • Jacobson Keyslides
    • Pipe Keyslides
  • Highlights Newsletter 3
    • PODCAST with prof. Arnon Kater about undetectable minimal residual disease in relapsed/refractory chronic lymphocytic leukemia patients following fixed-duration venetoclax-rituximab therapy
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 3
    • Wierda Keyslides
    • Locatelli Keyslides
    • Buske Keyslides
    • Wang Keyslides
  • Highlights Newsletter 4
    • PODCAST with dr. Tapan Kadia about adding venetoclax to cladribine + low dose AraC alternating with 5-azacytidine in older patients with newly diagnosed acute myeloid leukemia
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 4
    • Jaeger Keyslides
    • Wood Keyslides
    • Kaufman Keyslides
    • Hochhaus Keyslides
  • Highlights Newsletter 5
    • PODCAST with dr. Deepu Madduri about the phase 1b/2 CARTITUDE-1 study, examining ciltacabtagene autoleucel in relapsed/refractory multiple myeloma
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 5
    • Cutler Keyslides
    • Locatelli Keyslides
    • Frangoul Keyslides
    • Zeiser Keyslides
• EBMT2020
  • Highlights Newsletter 1
    • Podcast with dr. Anke Verlinden about the burden of CMV infection and real-life data of CMV prophylaxis
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 1
    • Ljungman Keyslides
    • Cordonnier Keyslides
    • Schmitt Keyslides
    • Soiffer Keyslides
• EHA 2020
  • Highlights Newsletter 1
    • PODCAST with prof. dr. Michel Delforge about the KarMMa trial
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 1
    • Wei Keyslides
    • Röth Keyslides
    • Garcia-Manero Keyslides
    • Dimopoulos Keyslides
  • Highlights Newsletter 2
    • PODCAST with prof. dr. Arnon Kater about the VENICE I-trial
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 2
    • Zeiser Keyslides
    • Dimopoulos Keyslides
    • Roufosse Keyslides
    • Platzbecker Keyslides
  • Highlights Newsletter 3
    • PODCAST with prof. Tiziano Barbui about ropeginterferon in patients with polycythemia vera
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 3
    • Siddiqi Keyslides
    • Zeidan Keyslides
    • Zijlstra Keyslides
    • Moreau Keyslides
  • Highlights Newsletter 4
    • PODCAST with dr. Efstathios Kastritis about the ANDROMEDA study regarding daratumumab in AL amyloidosis
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 4
    • Goldschmidt Keyslides
    • Hillmen Keyslides
    • Vergote Keyslides
    • Ghia Keyslides
  • Highlights Newsletter 5
    • PODCAST with dr. Courtney DiNardo about the VIALE-A study examining azacitidine in AML patients
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 5
    • Vergote Keyslides
    • Zeidan Keyslides
    • Moreau Keyslides
    • Hillmen Keyslides
  • Highlights Newsletter 6
    • PODCAST with dr. Paul Telfer about a national survey of COVID-19 in haemoglobinopathy and rare inherited anaemia patients
    • PODCAST with dr. George Goshua about COVID-19 associated coagulopathy
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
  • Keyslides Newsletter 6
    • Rambaldi Keyslides
    • Minniti Keyslides
    • Gaidano Keyslides
    • Falanga Keyslides
• ASH 2019
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with dr. Deepu Madduri
  • Keyslides Newsletter 1
    • Hajek Keyslides
    • Schuster Keyslides
    • Von Tresckow Keyslides
    • Rummel Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with dr. Jordan Schaefer
  • Keyslides Newsletter 2
    • Abramson Keyslides
    • Seymour Keyslides
    • D'Souza Keyslides
    • Broers Keyslides
  • Highlights Newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Dr. Patrick Brown
  • Keyslides Newsletter 3
    • Young Keyslides
    • Usmani Keyslides
    • Wei Keyslides
    • Bartlett Keyslides
  • Highlights Newsletter 4
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with dr. Guy Young
  • Keyslides Newsletter 4
    • Broers Keyslides
    • Wei Keyslides
    • Seymour Keyslides
    • Schuster Keyslides
• EHA 2019
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Prof. Philippe Moreau
  • Keyslides Newsletter 1
    • Howard Keyslides
    • Rule Keyslides
    • Fischer Keyslides
    • Le Gouill Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Christopher Hourigan
  • Keyslides Newsletter 2
    • Richardson Keyslides
    • Ghia Keyslides
    • Kumar Keyslides
    • Roschewski Keyslides
  • Highlights Newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Prof. Pierre Fenaux
  • Keyslides Newsletter 3
    • Tedeschi Keyslides
    • Mateos Keyslides
    • Gallamini Keyslides
    • Perl Keyslides
  • Highlights Newsletter 4
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Prof. Philippe Moreau
  • Keyslides Newsletter 4
    • Perl Keyslides
    • Le Gouill Keyslides
    • Roschewski Keyslides
    • Mateos Keyslides
• ASH 2018
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Prof. P. Sonneveld
  • Keyslides Newsletter 1
    • Fenaux Keyslides
    • Woyach Keyslides
    • Dimopoulos Keyslides
    • Grupp Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Dr. A. Khorana
  • Keyslides Newsletter 2
    • Connors Keyslides
    • Moreno Keyslides
    • Angelucci Keyslides
    • Poeschel Keyslides
  • Highlights Newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Dr. Tait Shanafelt
  • Keyslides Newsletter 3
    • Facon Keyslides
    • Maziarz Keyslides
    • Cappellini Keyslides
    • Seymour Keyslides
  • Highlights Newsletter 4
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with A. Khorana, MD, PhD
  • Keyslides Newsletter 4
    • Moreno Keyslides
    • Poeschel Keyslides
    • Facon Keyslides
    • Fenaux Keyslides
• EHA 2018
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Meletios Dimopoulos
  • Keyslides Newsletter 1
    • Hutchings Keyslides
    • Liu Keyslides
    • Gay Keyslides
    • Daver Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Video interview with Ann Janssens
    • Video interview with Frank Morschhauser
  • Keyslides Newsletter 2
    • Cortes Keyslides
    • Dimopoulos Keyslides
    • Casasnovas Keyslides
  • Highlights Newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Laurie Sehn
  • Keyslides Newsletter 3
    • Minarik Keyslides
    • Lee Keyslides
    • Ghia Keyslides
    • Clark Keyslides
  • Highlights Newsletter 4
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Jesus Berdeja
  • Keyslides Newsletter 4
    • Cortes Keyslides
    • Goede Keyslides
    • Lee Keyslides
    • Dimopoulos Keyslides
• ASH 2017
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Presentation 5
    • Videointerview with B. Hill, MD, PhD
  • Keyslides Newsletter 1
    • Young Keyslides
    • Martinelli Keyslides
    • Hillmen Keyslides
    • Neelapu Keyslides
    • Horwitz Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Presentation 5
    • Video interview with Daniel J. DeAngelo
  • Keyslides Newsletter 2
    • Connors Keyslides
    • Jackson Keyslides
    • Kim Keyslides
    • Schuster Keyslides
    • Mateos Keyslides
  • Highlights Newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Presentation 5
    • Video interview with Niels van de Donk
  • Keyslides Newsletter 3
    • Salles Keyslides
    • Richardson Keyslides
    • Scully Keyslides
    • Seymour Keyslides
    • Raskob Keyslides
• EHA 2017
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Prof. Martin Griesshammer
  • Keyslides Newsletter 1
    • Terpos Keyslides
    • Borchman Keyslides
    • Lazo-Langner Keyslides
    • Hamlin Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Prof. Gilles Salles
  • Keyslides Newsletter 2
    • Engert Keyslides
    • San-Miguel Keyslides
    • Zeijlemaker Keyslides
    • Ross Keyslides
  • Highlights Newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Karel Fostier, MD
  • Keyslides Newsletter 3
    • Cerchione Keyslides
    • Martin Keyslides
    • Lin Keyslides
    • Provan Keyslides
  • Highlights Newsletter 4
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video-interview with Prof. Dominique Bron
  • Keyslides Newsletter 4
    • Lin Keyslides
    • Borchmann Keyslides
    • San-Miguel Keyslides
    • Hamlin Keyslides
• ASH 2016
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video-interview with Dr. Srdan Verstovsek
  • Keyslides Newsletter 1
    • Garderet Keyslides
    • Copland Keyslides
    • Lancet Keyslides
    • Ataga Keyslides
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with T. Hughes MD, MBBS
  • Keyslides Newsletter 2
    • Di Bacco Keyslides
    • Marcus Keyslides
    • Topp Keyslides
    • Jaffray Keyslides
  • Highlights Newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video-interview with Prof. Marc André
  • Keyslides Newsletter 3
    • Davies Keyslides
    • George Keyslides
    • Mahon Keyslides
    • Schrappe Keyslides
• ASH 2015
  • Highlights Newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video-interview with Prof. Richard Stone
  • Keyslides Newsletter 1
    • Moreau Keyslides
    • Stilgenbauer Keyslides
    • Chai-Adisaksopha Keyslides
    • Raetz Keyslides
    • Video-interview with Prof. Richard Stone
  • Highlights Newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video-interview with Prof. Philippe Moreau
  • Keyslides Newsletter 2
    • Townsley Keyslides
    • Ramasamy Keyslides
    • Tedeschi Keyslides
    • Kochenderfer Keyslides
    • Video-interview with Prof. Philippe Moreau
  • Highlights newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Dr. Sébastien Maury
  • Keyslides newsletter 3
    • Ansell Keyslides
    • Avet-Loiseau Keyslides
    • Stilgenbauer Keyslides
    • Harrison Keyslides
    • Video interview with Dr. Sébastien Maury
• ASH 2014
  • Highlights newsletter 1
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Presentation 5
    • Video interview with Professor Timothy Devos
  • Keyslides newsletter 1
    • Roellig Keyslides
    • Niihara Keyslides
    • Lee Keyslides
    • Moskowitz Keyslides
    • Lipton Keyslides
  • Highlights newsletter 2
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Dr. Martin Müller
  • Keyslides newsletter 2
    • Büller Keyslides
    • Komrokji Keyslides
    • Ravandi Keyslides
    • Armand Keyslides
  • Highlights newsletter 3
    • Presentation 1
    • Presentation 2
    • Presentation 3
    • Presentation 4
    • Video interview with Prof. Marc André
  • Keyslides newsletter 3
    • Stewart Keyslides
    • Müller Keyslides
    • Wood Keyslides
    • Alvarnas Keyslides

• Highlights Newsletter 1
  • Podcast with Dr. Ahmed about real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma
  • Presentation 1
  • Presentation 2
  • Presentation 3
  • Presentation 4
• Highlights Newsletter 2
  • Podcast with Dr. Elias Jabbour about ponatinib versus imatinib treatment for patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia
  • Presentation 1
  • Presentation 2
  • Presentation 3
  • Presentation 4
• Keyslides Newsletter 2
  • Leppa Keyslides
  • Hochhaus Keyslides
  • Kater Keyslides
  • Wieduwilt Keyslides
• Highlights Newsletter 3
  • Podcast with Dr. Marco Ladetto about lenalidomide maintenance versus observation after autologous stem cell transplantations in patients with mantle cell lymphoma
  • Presentation 1
  • Presentation 2
  • Presentation 3
  • Presentation 4
• Keyslides Newsletter 3
  • Mehta Keyslides
  • Langerbeins Keyslides
  • Dimopoulos Keyslides
  • Jin Keyslides
• Highlights Newsletter 4
  • Podcast with Dr. Ahmed about real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma
  • Presentation 1
  • Presentation 2
  • Presentation 3
  • Presentation 4
• Keyslides Newsletter 4
  • Patel Keyslides
  • Sureda Keyslides
  • Mehta Keyslides
  • Platzbecker Keyslides

• Highlights Newsletter 1
  • Podcast with Dr. Jeff Sharman about the 6-year follow-up results of the ELEVATE-TN trial evaluating acalabrutinib treatment in CLL patients
  • Presentation 1
  • Presentation 2
  • Presentation 3
• Keyslides Newsletter 1
  • Sonneveld Keyslides
  • Wang Keyslides
  • Othman Keyslides
• Highlights Newsletter 2
  • Podcast with Prof. Steven Pipe about the results from HOPE-B evaluating gene therapy in adult patients with severe or moderately severe haemophilia B
  • Presentation 1
  • Presentation 2
  • Presentation 3
• Keyslides Newsletter 2
  • Harrison Keyslides
  • Garcia-Manero Keyslides
  • Hillmen Keyslides
• Highlights Newsletter 3
  • Podcast with Prof. Gertjan Kaspers about the use of MRD-based risk stratification in the NOPHO-DBH AML 2012 protocol for the treatment of paediatric AML patients
  • Presentation 1
  • Presentation 2
  • Presentation 3
• Keyslides Newsletter 3
  • Gay Keyslides
  • Abboud Keyslides
  • Shadman Keyslides
• Highlights Newsletter 4
  • Podcast with Dr. Salaroli about the 4-year results of the ASCEMBL study comparing asciminib with bosutinib for patients with chronic myeloid leukaemia in chronic phase
  • Presentation 1
  • Presentation 2
  • Presentation 3
• Keyslides Newsletter 4
  • Pemmaraju Keyslides
  • Pipe Keyslides
  • Phillips Keyslides